WALTHAM, Mass.– At the American Association for Cancer Research 2012 Annual Meeting (Booth #2306), PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it will be showcasing numerous solutions, posters and knowledge-sharing events in support of cancer-focused personalized medicine research.

“PerkinElmer remains committed to the fight against cancer through enabling personalized medicine solutions that allow researchers to find, understand, and act upon the causes and processes of the disease,” said Kevin Hrusovsky, President, Life Sciences & Technology, PerkinElmer. “We are passionate about helping academic, biopharma and clinical researchers to achieve new insights for discovering advanced therapeutics and diagnostics to reduce the threat of cancer. Our solutions in Next Generation Sequencing, advanced cellular, in vitro and in vivo imaging, automation instrumentation, and reagent technologies, provide researchers the critical tools they need to combat this deadly disease.”

On the evening of Tuesday, April 3, PerkinElmer will be hosting an event, entitled

“The Revolutionizing Medicine Rock ‘n’ Roll Reception,” featuring distinguished speakers who are committed to the fight against cancer, discussing how personalized medicine is changing research and treatment of the disease. The event will also feature performances by Molecular Groove, the PerkinElmer band.

• Tuesday, April 3, 6:30 PM – 10:30 PM

• Hyatt Regency McCormick Place, Regency Ballroom

Featured speakers at the event include clinical, academic and industry thought leaders in personalized medicine for cancer, such as:

• Raju Kucherlapati Ph.D., Professor of Genetics and Medicine, Harvard University, who will speak on “Personalized Medicine in Cancer”

• James P. Basilion, Ph.D., Associate Professor, Departments of Radiology, Biomedical Engineering, and Pathology, Case Western Reserve University, whose discussion topic is “Defining the Cutting Edge”

• Kevin Hrusovsky, President, Life Sciences & Technology, PerkinElmer, who will present on “Next Generation Innovations Enabling an Advancement in Health”

PerkinElmer solutions for enabling personalized medicine-based cancer research on display at AACR 2012 include:

• The NGS Express™ Automated Liquid Handling Workstation – a compact flexible and easy-to-use library prep system for benchtop sequencers that offers efficient sample preparation for up to 24 Next Generation Sequencing libraries, and eliminates the need for time-consuming protocol development.

• FolateRSense™ and TLectinSense™ Fluorescent Preclinical Imaging Agents, designed to be used by in vivo imaging systems, and for the quantitation and longitudinal study of tumor growth and vascularization.

• AlphaLISA® cellular epigenetics detection kits, a no-wash homogeneous proximity immunoassay to detect specific methylation and acetylation states for epigenetics research.

PerkinElmer instruments and software featured at AACR include:

• LabChip® GX Nucleic Acid Separation System

• JANUS® Automated Liquid Handling Workstation

• Operetta® High Content Imaging System

• VectraTM 2 Automated Slide Imaging system

• FMT® Quantitative Fluorescence Tomography Imaging System

• EnSpire® Multimode Plate Reader

• ColumbusTM Image Storage and Analysis Software

• UltraVIEW® Vox 3D Live Cell Imaging System

• Volocity® 3D Image Analysis Software

• Geospiza® Genesifter® Genetic Analysis Software